Successful living donor liver transplantation from an HIV and HCV positive donor: report from the first case in the world

AIDS. 2023 Jul 1;37(8):1257-1261. doi: 10.1097/QAD.0000000000003533. Epub 2023 Mar 3.

Abstract

HIV (human-immunodeficiency-virus) and HCV (hepatitis-C-virus) infections cause millions of deaths across the world every year. Since the introduction of effective therapies for HIV, in the middle of 1990s, and HCV, after 2013, those two untreatable infections became completely controlled. Donor safety is the main goal in living donor liver transplantation (LDLT). An accurate predonation screening is mandatory for excluding risk factors related with any increase of donors' short-term and long-term morbidity. We present the first LDLT from a donor with both HIV and HCV previous infections. Donor and recipient did not experience any complication. Individuals with well controlled HIV/HCV infections and without any risk factors may be suitable for donation of a part of their healthy liver. Abstract video, http://links.lww.com/QAD/C833.

MeSH terms

  • HIV
  • HIV Infections* / complications
  • HIV Infections* / diagnosis
  • Hepacivirus
  • Hepatitis C* / complications
  • Humans
  • Liver Transplantation*
  • Living Donors